These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3353892)
1. Low serum testosterone as an indicator of metastatic bronchial carcinoma. Moore-Gillon J Thorax; 1988 Feb; 43(2):159-60. PubMed ID: 3353892 [No Abstract] [Full Text] [Related]
2. Low serum testosterone as an indicator of metastatic bronchial carcinoma. Taggart DP; Gray C; Davidson KG; Faichney A Thorax; 1987 Sep; 42(9):661-3. PubMed ID: 3686457 [TBL] [Abstract][Full Text] [Related]
3. [Behavior of serum hyaluronic acid in bronchial carcinoma]. MASENTI E; MERLO G Minerva Chir; 1960 Mar; 15():264-7. PubMed ID: 14421998 [No Abstract] [Full Text] [Related]
4. Circulating hormones in lung cancer. Behera D; Malik SK; Sharma BR; Dash RJ Indian J Med Res; 1984 May; 79():636-40. PubMed ID: 6096269 [No Abstract] [Full Text] [Related]
5. Serum hCG in bronchogenic carcinoma. Behera D; Dash S; Malik SK; Dash RJ Indian J Chest Dis Allied Sci; 1984; 26(4):238-41. PubMed ID: 6545265 [No Abstract] [Full Text] [Related]
6. [Significance of the relative seimentation rate in the diagnosis of bronchial carcnoma]. Eiter E Wien Med Wochenschr; 1967 Mar; 117(11):268-70. PubMed ID: 5585998 [No Abstract] [Full Text] [Related]
13. Erythrocyte fatty acid profiles in patients with bronchogenic carcinoma. Taylor A; Manche A; Wilson I; Watson D; Pandov H; Lawson N Ann Clin Biochem; 1987 Nov; 24 ( Pt 6)():604-7. PubMed ID: 3426127 [TBL] [Abstract][Full Text] [Related]
14. [The behavior of trace elements in bronchial carcinoma]. Dawczynski H; Bartel M; Wagner W Z Exp Chir Transplant Kunstliche Organe; 1988; 21(6):344-7. PubMed ID: 3223012 [TBL] [Abstract][Full Text] [Related]
15. Serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma. Tani P; Kokkola K Scand J Respir Dis Suppl; 1972; 80():121-8. PubMed ID: 4510909 [No Abstract] [Full Text] [Related]
16. The presence of malignant cells in the blood of patients with carcinoma of the lung. SAKURAI M; KLASSEN KP; SELBACH GJ Acta Cytol; 1962; 6():314-8. PubMed ID: 14496235 [No Abstract] [Full Text] [Related]
17. Fibrinolysis in human bronchogenic carcinoma. Peterson HI; Larsson S; Zettergren L Bibl Anat; 1975; 13():315-6. PubMed ID: 182114 [No Abstract] [Full Text] [Related]
18. Blood coagulation and fibrinolysis in patients with carcinoma of the lung. Brugarolas A; Elias EG; Takita H; Mink IB; Mittelman A; Ambrus JL J Med; 1973; 4(2):96-105. PubMed ID: 4127138 [No Abstract] [Full Text] [Related]
19. Tissue polypeptide antigen in bronchogenic carcinoma. Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159 [TBL] [Abstract][Full Text] [Related]
20. Factor VIII inhibitor and bronchogenic carcinoma. Al-Ismail SA; Parry DH; Moisey CU; Bloom AL Thromb Haemost; 1979 Apr; 41(2):291-5. PubMed ID: 473113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]